ITGA4 polymorphisms and susceptibility to multiple sclerosis

Catherine King, Izaura M. Roos, Alfredo Antiguedad, Ana M. Aransay, Jan Hillert, Koen Vandenbroeck

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In multiple sclerosis (MS), α4β1 integrin, also known as Very Late Antigen 4 (VLA4), facilitates migration of leukocytes across the blood brain barrier. Several studies suggest that expression of α4 integrin may be increased in MS patients compared to controls, and down-regulation or antagonism of α4 integrin may be associated with immunomodulatory treatment success. We analysed association of 13 single nucleotide polymorphisms (SNPs) in the gene encoding α4 integrin (ITGA4) with susceptibility to MS in two distinct populations comprising cases and controls from the Basque Country in northern Spain (352 patients; 235 controls) and Nordic countries (1119 patients; 1235 controls). Carriage of the C allele of the ITGA4 promoter SNP rs1449263 was independently and weakly increased in MS patients from each population compared to respective controls (P = 0.037 in Basque; and P = 0.042 in Nordic cohorts), though these associations were lost upon application of permutation correction. Meta-analysis of rs1449263*C carriage revealed a Mantel-Haenszel common OR of 1.26 (95% CI 1.06-1.49; P = 0.0069). Though our data only modestly argue for a role of ITGA4 in determining susceptibility to MS, we suggest that further examination of this gene, particularly the promoter region, is warranted.

LanguageEnglish
Pages151-157
Number of pages7
JournalJournal of Neuroimmunology
Volume189
Issue number1-2
DOIs
Publication statusPublished - 1 Sep 2007
Externally publishedYes

Keywords

  • Genetic
  • Integrin
  • ITGA4
  • Multiple sclerosis
  • Natalizumab
  • Polymorphism

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

King, C., Roos, I. M., Antiguedad, A., Aransay, A. M., Hillert, J., & Vandenbroeck, K. (2007). ITGA4 polymorphisms and susceptibility to multiple sclerosis. Journal of Neuroimmunology, 189(1-2), 151-157. https://doi.org/10.1016/j.jneuroim.2007.07.006
King, Catherine ; Roos, Izaura M. ; Antiguedad, Alfredo ; Aransay, Ana M. ; Hillert, Jan ; Vandenbroeck, Koen. / ITGA4 polymorphisms and susceptibility to multiple sclerosis. In: Journal of Neuroimmunology. 2007 ; Vol. 189, No. 1-2. pp. 151-157.
@article{bad20c12e30e44d5a57ea77d51d867d2,
title = "ITGA4 polymorphisms and susceptibility to multiple sclerosis",
abstract = "In multiple sclerosis (MS), α4β1 integrin, also known as Very Late Antigen 4 (VLA4), facilitates migration of leukocytes across the blood brain barrier. Several studies suggest that expression of α4 integrin may be increased in MS patients compared to controls, and down-regulation or antagonism of α4 integrin may be associated with immunomodulatory treatment success. We analysed association of 13 single nucleotide polymorphisms (SNPs) in the gene encoding α4 integrin (ITGA4) with susceptibility to MS in two distinct populations comprising cases and controls from the Basque Country in northern Spain (352 patients; 235 controls) and Nordic countries (1119 patients; 1235 controls). Carriage of the C allele of the ITGA4 promoter SNP rs1449263 was independently and weakly increased in MS patients from each population compared to respective controls (P = 0.037 in Basque; and P = 0.042 in Nordic cohorts), though these associations were lost upon application of permutation correction. Meta-analysis of rs1449263*C carriage revealed a Mantel-Haenszel common OR of 1.26 (95{\%} CI 1.06-1.49; P = 0.0069). Though our data only modestly argue for a role of ITGA4 in determining susceptibility to MS, we suggest that further examination of this gene, particularly the promoter region, is warranted.",
keywords = "Genetic, Integrin, ITGA4, Multiple sclerosis, Natalizumab, Polymorphism",
author = "Catherine King and Roos, {Izaura M.} and Alfredo Antiguedad and Aransay, {Ana M.} and Jan Hillert and Koen Vandenbroeck",
year = "2007",
month = "9",
day = "1",
doi = "10.1016/j.jneuroim.2007.07.006",
language = "English",
volume = "189",
pages = "151--157",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

King, C, Roos, IM, Antiguedad, A, Aransay, AM, Hillert, J & Vandenbroeck, K 2007, 'ITGA4 polymorphisms and susceptibility to multiple sclerosis', Journal of Neuroimmunology, vol. 189, no. 1-2, pp. 151-157. https://doi.org/10.1016/j.jneuroim.2007.07.006

ITGA4 polymorphisms and susceptibility to multiple sclerosis. / King, Catherine; Roos, Izaura M.; Antiguedad, Alfredo; Aransay, Ana M.; Hillert, Jan; Vandenbroeck, Koen.

In: Journal of Neuroimmunology, Vol. 189, No. 1-2, 01.09.2007, p. 151-157.

Research output: Contribution to journalArticle

TY - JOUR

T1 - ITGA4 polymorphisms and susceptibility to multiple sclerosis

AU - King, Catherine

AU - Roos, Izaura M.

AU - Antiguedad, Alfredo

AU - Aransay, Ana M.

AU - Hillert, Jan

AU - Vandenbroeck, Koen

PY - 2007/9/1

Y1 - 2007/9/1

N2 - In multiple sclerosis (MS), α4β1 integrin, also known as Very Late Antigen 4 (VLA4), facilitates migration of leukocytes across the blood brain barrier. Several studies suggest that expression of α4 integrin may be increased in MS patients compared to controls, and down-regulation or antagonism of α4 integrin may be associated with immunomodulatory treatment success. We analysed association of 13 single nucleotide polymorphisms (SNPs) in the gene encoding α4 integrin (ITGA4) with susceptibility to MS in two distinct populations comprising cases and controls from the Basque Country in northern Spain (352 patients; 235 controls) and Nordic countries (1119 patients; 1235 controls). Carriage of the C allele of the ITGA4 promoter SNP rs1449263 was independently and weakly increased in MS patients from each population compared to respective controls (P = 0.037 in Basque; and P = 0.042 in Nordic cohorts), though these associations were lost upon application of permutation correction. Meta-analysis of rs1449263*C carriage revealed a Mantel-Haenszel common OR of 1.26 (95% CI 1.06-1.49; P = 0.0069). Though our data only modestly argue for a role of ITGA4 in determining susceptibility to MS, we suggest that further examination of this gene, particularly the promoter region, is warranted.

AB - In multiple sclerosis (MS), α4β1 integrin, also known as Very Late Antigen 4 (VLA4), facilitates migration of leukocytes across the blood brain barrier. Several studies suggest that expression of α4 integrin may be increased in MS patients compared to controls, and down-regulation or antagonism of α4 integrin may be associated with immunomodulatory treatment success. We analysed association of 13 single nucleotide polymorphisms (SNPs) in the gene encoding α4 integrin (ITGA4) with susceptibility to MS in two distinct populations comprising cases and controls from the Basque Country in northern Spain (352 patients; 235 controls) and Nordic countries (1119 patients; 1235 controls). Carriage of the C allele of the ITGA4 promoter SNP rs1449263 was independently and weakly increased in MS patients from each population compared to respective controls (P = 0.037 in Basque; and P = 0.042 in Nordic cohorts), though these associations were lost upon application of permutation correction. Meta-analysis of rs1449263*C carriage revealed a Mantel-Haenszel common OR of 1.26 (95% CI 1.06-1.49; P = 0.0069). Though our data only modestly argue for a role of ITGA4 in determining susceptibility to MS, we suggest that further examination of this gene, particularly the promoter region, is warranted.

KW - Genetic

KW - Integrin

KW - ITGA4

KW - Multiple sclerosis

KW - Natalizumab

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=34548473593&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2007.07.006

DO - 10.1016/j.jneuroim.2007.07.006

M3 - Article

VL - 189

SP - 151

EP - 157

JO - Journal of Neuroimmunology

T2 - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -

King C, Roos IM, Antiguedad A, Aransay AM, Hillert J, Vandenbroeck K. ITGA4 polymorphisms and susceptibility to multiple sclerosis. Journal of Neuroimmunology. 2007 Sep 1;189(1-2):151-157. https://doi.org/10.1016/j.jneuroim.2007.07.006